Short and intermediate clinical outcome after late coronary stenting in myocardial infarction

P Uerojanaungkul1, C Piamsomboon, C Roongsritong

  • 1Department of Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand.

Insights

Late coronary stenting after acute myocardial infarction (AMI) is feasible and safe, showing improved heart function and clinical outcomes. This procedure offers a favorable intermediate prognosis for patients with AMI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • The open artery theory suggests late reperfusion improves outcomes in acute myocardial infarction (AMI).
  • Coronary angioplasty with stenting is a primary method for reperfusion in AMI.
  • Limited data exists on the intermediate outcomes of late angioplasty with stenting.

Purpose of the Study:

  • To evaluate the feasibility and intermediate clinical outcomes of late coronary stenting in patients with AMI.
  • To assess changes in left ventricular ejection fraction (LVEF) following the procedure.

Main Methods:

  • A prospective study involving 44 patients with AMI who underwent late coronary stenting between June 1998 and August 1999.
  • Echocardiography was performed pre-procedure and at 6-month follow-up.
  • Data collected included procedural success, in-hospital events, and intermediate clinical outcomes.

Main Results:

  • Coronary stenting was successful in all patients, significantly reducing diameter stenosis.
  • In-hospital mortality was 2.27% due to sudden cardiac death.
  • At a mean follow-up of 11.4 months, there was 1 myocardial infarction (2.3%), 2 cases of congestive heart failure (4.65%), and no cardiac deaths. Left ventricular ejection fraction (LVEF) significantly improved (47.75% to 54.89%, p < 0.001).

Conclusions:

  • Late coronary stenting in the infarct-related artery of AMI patients is a feasible procedure with a low complication rate.
  • The study demonstrated improved LVEF and favorable intermediate clinical outcomes, supporting the open artery theory.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...